Clinical Trial Suggests Cannabinoids Effective at Treating Insomnia

A group of researchers from the University of California applied for a research grant to investigate the effects of marijuana and cannabidiol (CBD), the main ingredient in cannabis, on sleep. The findings of their study suggest that the cannabinoids are as effective as the popular prescription drug Ambien – a non-prescription sleep aid – in reducing the number of hours a person sleeps. The study also showed that the non-psychoactive form of cannabidiol, called cannabidiolic acid (CBDA), was just as effective at reducing insomnia, while marijuana itself was not. The research was published in the journal Science Translational Medicine .

A new clinical trial suggests that cannabidiol (CBD) is the safest and most effective drug to use for the treatment of insomnia. The study, published in the Journal of Clinical Sleep Medicine, provides evidence that CBD is more effective than the prescription drug zolpidem (Ambien, Stilnox) and other prescription drugs.

Scientists have long known that cannabis can be used to treat insomnia. But, while initial studies have suggested that it works, they have never been able to produce conclusive evidence that cannabis can actually cure the disease. This is the first clinical trial to provide evidence that cannabis is therapeutically effective at treating insomnia.

Insomnia is a serious problem all over the world.

It is estimated that 60% of the world’s population suffers from sleep disorders.

Lack of adequate sleep can be caused by many factors. Insomnia comes in two forms.

The first is primary insomnia, where the sleep disorder is not related to another condition.

Secondary insomnia is when the inability to sleep is caused by one or more other conditions, such as. B. Asthma, heartburn or cancer.

Both forms of insomnia can occur as an isolated event that lasts only a day or two, or as a persistent problem over a significant period of time.

Cannabis as a sedative

A team of Australian researchers conducted a clinical trial in which part of the cohort received a placebo and the rest a sublingual preparation of cannabis extract (ZTL-101).

Twenty-three people participated in the study, all of whom suffered from insomnia.

The subjects took either the placebo or the extract every night for two weeks one hour before bedtime.

ZTL-101 contains THC, CBD, CBN and several terpenes. It is a sublingual tincture-like preparation that patients place under the tongue.

The results of the clinical trials were encouraging.

This study showed that ZTL-101, a new cannabinoid-based treatment, is well tolerated and improves insomnia symptoms and sleep quality in people with chronic insomnia.

Based on previous research

The above clinical trial was sponsored by a cannabis company, so some skepticism about the study is understandable.

It is important to put the results of the study in context.

Several other studies have also shown that cannabis can help treat people with insomnia.

As Cannabis & Tech Today also reports, a recent survey of insomnia patients found that nearly two-thirds of study participants reported decreased insomnia severity and improved quality of life after using medicinal cannabis.

A 2018 analysis of data from insomnia patients also found significant improvements in study participants who used cannabis before bed.

Many other studies have also shown that cannabis is an effective and safe treatment for insomnia.

More research is needed on the specific drug (ZTL-101) used in this latest study, but the general principle that cannabis can successfully treat insomnia, at least in some cases, seems to hold true.We still don’t know the exact mechanisms by which cannabinoids alleviate insomnia, but there are some ideas. Some believe that the endocannabinoid system (the same system that cannabinoids affect) affects the brain’s circadian rhythm, which in turn prevents it from going into a deep sleep state. Others believe that cannabinoids help inhibit the release of cytokines that cause inflammation in the brain, causing sleep to become more restorative. Some researchers believe that cannabinoids help inhibit the release of brain chemicals that cause insomnia.. Read more about zenivol and let us know what you think.

zelira therapeuticscannabinoids in clinical practicecbd anxiety studycbg clinical trialscbd slow wave sleepthe use of cannabinoids for sleep: a critical review on clinical trials,People also search for,Privacy settings,How Search works,the use of cannabinoids for sleep: a critical review on clinical trials,cannabinoids in the treatment of insomnia disorder: a systematic review and meta-analysis.,ztl-101,cbd clinical trials australia,zenivol,zelira therapeutics,cannabidiol clinical trials,effects of cannabinoids on sleep and their therapeutic potential for sleep disorders

You May Also Like